Cargando…

Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014

OBJECTIVE: The aim of this study was to estimate the proportion of rubella disease in a measles case-based surveillance in Cameroon prior to rubella vaccine introduction into the national immunisation programme. DESIGN: This was a cross-sectional study for rubella infection in Cameroon for the perio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nimpa Mengouo, Marcellin, Ndze, Valantine Ngum, Baonga, Frangy, Kobela, Marie, Wiysonge, Charles Shey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Open 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594209/
https://www.ncbi.nlm.nih.gov/pubmed/28389483
http://dx.doi.org/10.1136/bmjopen-2016-012959
_version_ 1783263165804445696
author Nimpa Mengouo, Marcellin
Ndze, Valantine Ngum
Baonga, Frangy
Kobela, Marie
Wiysonge, Charles Shey
author_facet Nimpa Mengouo, Marcellin
Ndze, Valantine Ngum
Baonga, Frangy
Kobela, Marie
Wiysonge, Charles Shey
author_sort Nimpa Mengouo, Marcellin
collection PubMed
description OBJECTIVE: The aim of this study was to estimate the proportion of rubella disease in a measles case-based surveillance in Cameroon prior to rubella vaccine introduction into the national immunisation programme. DESIGN: This was a cross-sectional study for rubella infection in Cameroon for the period 2008 to 2014. SETTING: Patients suspected with measles from the 10 regions of Cameroon were recruited according to the WHO measles case definition and were tested for rubella IgM antibodies accompanied with the case report/investigation forms. PARTICIPANTS: All persons with rash and fever within 14 days of onset of rash according to the standard WHO African Regional Office (WHO/AFRO) case definition for a suspected measles case. OUTCOME MEASURES: Descriptive analyses and simple logistic regressions were performed. OR were estimated. RESULTS: A total of 9907 serum samples from people with fever and rash were received in the laboratory from 2008 to 2014. A total of 7489 (75.59%) measles-negative samples were tested for rubella; 699 (9.3%) were positive for rubella IgM antibodies. Logistic regression analysis was done using IgM antibodies detection as the outcome variable. Age, sex and setting were explanatory variables. Logistic regression analysis revealed that, comparing the proportion of rubella IgM seropositivity status by age, the association to a positive rubella IgM increased with age from 1 to 4 years (OR 7.11; 95% CI 4.35 to 12.41; p<0.0001), through 5 to 9 years (OR 13.07; 95% CI 7.93 to 22.93; p<0.001), to 10 to 14 years of age (OR 13.86; 95% CI 8.06 to 25.12; p<0.001). Persons aged ≥15 years were also more likely to have rubella infection than children under one (OR 3.69; 95% CI 1.85 to 7.48; p=0.0001). There were also significant associations with sex, with males being less associated to a positive rubella serology than females (OR 1.33; 95% CI 1.14 to 1.56; p=0.0001). No statistically significant difference in proportion of rubella cases was observed between urban and rural populations (OR 1.11; 95% CI 0.94 to 1.31; p=0.208). CONCLUSIONS: This study reveals that rubella virus circulates in Cameroon, with important number of cases in children under 15 years. This finding supports the planned introduction of rubella-containing vaccines into the Expanded Program on Immunization.
format Online
Article
Text
id pubmed-5594209
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Open
record_format MEDLINE/PubMed
spelling pubmed-55942092017-09-14 Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014 Nimpa Mengouo, Marcellin Ndze, Valantine Ngum Baonga, Frangy Kobela, Marie Wiysonge, Charles Shey BMJ Open Epidemiology and Global Health OBJECTIVE: The aim of this study was to estimate the proportion of rubella disease in a measles case-based surveillance in Cameroon prior to rubella vaccine introduction into the national immunisation programme. DESIGN: This was a cross-sectional study for rubella infection in Cameroon for the period 2008 to 2014. SETTING: Patients suspected with measles from the 10 regions of Cameroon were recruited according to the WHO measles case definition and were tested for rubella IgM antibodies accompanied with the case report/investigation forms. PARTICIPANTS: All persons with rash and fever within 14 days of onset of rash according to the standard WHO African Regional Office (WHO/AFRO) case definition for a suspected measles case. OUTCOME MEASURES: Descriptive analyses and simple logistic regressions were performed. OR were estimated. RESULTS: A total of 9907 serum samples from people with fever and rash were received in the laboratory from 2008 to 2014. A total of 7489 (75.59%) measles-negative samples were tested for rubella; 699 (9.3%) were positive for rubella IgM antibodies. Logistic regression analysis was done using IgM antibodies detection as the outcome variable. Age, sex and setting were explanatory variables. Logistic regression analysis revealed that, comparing the proportion of rubella IgM seropositivity status by age, the association to a positive rubella IgM increased with age from 1 to 4 years (OR 7.11; 95% CI 4.35 to 12.41; p<0.0001), through 5 to 9 years (OR 13.07; 95% CI 7.93 to 22.93; p<0.001), to 10 to 14 years of age (OR 13.86; 95% CI 8.06 to 25.12; p<0.001). Persons aged ≥15 years were also more likely to have rubella infection than children under one (OR 3.69; 95% CI 1.85 to 7.48; p=0.0001). There were also significant associations with sex, with males being less associated to a positive rubella serology than females (OR 1.33; 95% CI 1.14 to 1.56; p=0.0001). No statistically significant difference in proportion of rubella cases was observed between urban and rural populations (OR 1.11; 95% CI 0.94 to 1.31; p=0.208). CONCLUSIONS: This study reveals that rubella virus circulates in Cameroon, with important number of cases in children under 15 years. This finding supports the planned introduction of rubella-containing vaccines into the Expanded Program on Immunization. BMJ Open 2017-04-07 /pmc/articles/PMC5594209/ /pubmed/28389483 http://dx.doi.org/10.1136/bmjopen-2016-012959 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Epidemiology and Global Health
Nimpa Mengouo, Marcellin
Ndze, Valantine Ngum
Baonga, Frangy
Kobela, Marie
Wiysonge, Charles Shey
Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
title Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
title_full Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
title_fullStr Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
title_full_unstemmed Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
title_short Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
title_sort epidemiology of rubella infection in cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008–2014
topic Epidemiology and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594209/
https://www.ncbi.nlm.nih.gov/pubmed/28389483
http://dx.doi.org/10.1136/bmjopen-2016-012959
work_keys_str_mv AT nimpamengouomarcellin epidemiologyofrubellainfectionincameroona7yearexperienceofmeaslesandrubellacasebasedsurveillance20082014
AT ndzevalantinengum epidemiologyofrubellainfectionincameroona7yearexperienceofmeaslesandrubellacasebasedsurveillance20082014
AT baongafrangy epidemiologyofrubellainfectionincameroona7yearexperienceofmeaslesandrubellacasebasedsurveillance20082014
AT kobelamarie epidemiologyofrubellainfectionincameroona7yearexperienceofmeaslesandrubellacasebasedsurveillance20082014
AT wiysongecharlesshey epidemiologyofrubellainfectionincameroona7yearexperienceofmeaslesandrubellacasebasedsurveillance20082014